Expert consensus on treatment for stage III non‐small cell lung cancer
Stage III non‐small cell lung cancer (NSCLC) encompasses a group of diseases with high
heterogeneity. Such patients should actively receive comprehensive treatments. It is …
heterogeneity. Such patients should actively receive comprehensive treatments. It is …
Expert consensus on treatment for stage Ⅲ non-small cell lung cancer
YL Wu, S Lu, Q Zhou, L Zhang, Y Cheng, J Wang… - Medicine …, 2023 - sciopen.com
Stage Ⅲ non-small cell lung cancer (NSCLC) encompasses a group of diseases with high
heterogeneity. Such patients should actively receive comprehensive treatments. It is …
heterogeneity. Such patients should actively receive comprehensive treatments. It is …